Sorin Medical Device Company Intelligence Report

Date: June 30, 2012
Pages: 42
Price:
US$ 515.00
Publisher: Espicom Business Intelligence
Report type: Company Report
Delivery: E-mail Delivery (PDF)
ID: S1D25520605EN
Leaflet:

Download PDF Leaflet

Sorin Medical Device Company Intelligence Report
Sorin develops and manufactures medical technologies and therapies for cardiac surgery and for the treatment of cardiac rhythm disorders. At the end of 2008, the company completed a programme of strategic divestitures and concluded a plan to restructure its business portfolio. The divestitures included the sale of its endovascular, coronary stent and renal care businesses. This has allowed the company to better focus on its three core businesses – Cardiac Rhythm Management (CRM), Cardiopulmonary and Heart Valves.

The CRM business produces pacemakers, implantable cardioverter defibrillators (ICDs), cardiac resynchronisation therapy defibrillators (CRT-Ds), programmers, electrodes, electrophysiology leads and holter monitors.

The Cardiopulmonary business produces extracorporeal blood circulation systems including oxygenators, heart-lung machines, perfusion tubing sets, autotransfusion systems and disposables, cannulae and endoscopic vessel harvesting (EVH) systems.

The Heart Valves business offers mechanical heart valves, tissue heart valves, sutureless self-anchoring tissue valves and annuloplasty rings. Sorin is also a distributor of endovascular devices.

Sorin’s recent investments in developing its business include the purchase of equity stakes in Enopace Biomedical (a company developing a neuromodulation system to treat patients with congestive heart failure) and MD Start (a venture capital incubator), as well as the acquisition of a line of arterial and venous cannulae from Endoscopic Technologies Inc and the purchase of Gish Biomedical (a producer of disposable medical devices for cardiovascular surgery).

Sorin’s principal manufacturing and R&D facilities are located in Italy, France, Germany, Canada and the US. The company is present in more than 80 countries throughout the world and serves over 5,000 public and private health institutions.

The Sorin Group was created through the demerger of Snia’s biomedical operations. It was listed separately on the Online Stock Market of the Milan Securities Exchange in January 2004. As of January 2012, its main shareholders included: Bios SpA (19.1%); Tower 6Bis Sarl (6.7%); Banca Monte Dei Paschi di Siena SpA (7.3%); Unipol Assicurazioni SpA (4.6%); GE Capital Equity Holdings (6.4%); and Norges Bank (2.0%).

In 2011, Sorin generated net income of EUR58 million on sales of EUR743 million. The company employs more than 3,740 people worldwide.

This company report provides

Overview
  • Key contact information
  • Introduction to the company and its current activities
  • Summary of its financial performance
  • Who are the company’s major competitors?
  • Key recent events in an “at a glance” format
Financial Review
  • Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
  • Table providing in-depth five-year financial analysis
  • Employee data, including breakdown by company division and geographic location
Strategic Focus
  • Investigates the company’s aims and its areas of focus
Products
  • Core product areas, key brands, product approvals and launches
Research and Development
  • How much has been invested in R&D?
  • Where is the research based?
  • What alliances and agreements does the company have and with whom?
Manufacturing and Distribution
  • Identifying the company’s manufacturing locations
  • Sales and marketing facilities
Agreements
  • With whom has the company reached agreements and what do they involve?
  • Key contracts awarded
Mergers, Acquisitions, Minority Investments, Joint Ventures and Divestments
Litigation
Key Corporate Events
OVERVIEW

FINANCIAL REVIEW

First Quarter 2012 Financial Results
2011 Financial results
  Cardiopulmonary
  CRM
  Heart Valves
  Sales by Geographic Region
Five-Year Financial Data
Outlook
Employees

STRATEGIC FOCUS

PRODUCTS

Cardiopulmonary
  Heart-lung Machines
  Oxygenators
  Autotransfusion Systems
  Endoscopic Vessel Harvesting (EVH)
Cardiac Rhythm Management (CRM)
  Pacemakers
  ICDs and CRT-Ds
  Arrhythmia Assessment Devices
Heart Valves

RESEARCH AND DEVELOPMENT

R&D Expenditure
R&D Facilities
R&D Activities
  Cardiopulmonary Business
  CRM Business
  Heart Valves Business
Studies and Trials
  DREAM Clinical Trial
  CLEAR Study
  Freedom Solo IDE Study
  ISIS-ICD Clinical Trial
  RESPOND Clinical Trial
  SonEx Clinical Trial

MANUFACTURING

AGREEMENTS

California Medical Laboratories
CardioMedical
Japan Lifeline
Orange Business Services
Sphere Medical
Greatbatch
Vertellus Biomaterials
Medtronic

MERGERS AND ACQUISITIONS

Italian Distributor
Endoscopic Technologies Assets
Dutch Distributor
Gish Biomedical
Austrian Distributor
Dutch Distributor
Datascope’s Endoscopic Vessel Harvesting Product Line
Ela Medical Cormedica Lda
Carbomedics and Mitroflow
Soludia
Ela Medical
Angeion Cardiac Stimulation Technology
Cobe CV
Dideco
Bellco
Sorin Biomedica

MINORITY INVESTMENTS

Enopace Biomedical
MD Start
Sphere Medical
Other
  Istituto Europeo di Oncologia
  Consorzio Medal Energia
  La Bouscarre S.C.I
  Laser und Medizin Technologie GmbH

JOINT VENTURES

Ela Medical Izasa

DIVESTITURES

Angel and activAT Product Lines
Renal Care Business
Vascular Therapy Business
Peripheral Stent Business
Sorin Group Japan
Sorin LifeWatch (Telemedicine Joint Venture)
Diagnostics Business
Tracheostomy Products Business

KEY CORPORATE EVENTS

LIST OF TABLES

SUMMARY OPERATING RESULTS
Recent Key Events
Sorin - First Quarter 2012 Financial Results
Sorin - First Quarter 2012 Revenues by Business Segment
Sorin - First Quarter 2012 Revenues by Geographic Area
Sorin - Annual Financial Results, 2007-2011
Sorin - Annual Revenues by Business Segment, 2007-2011
Sorin - Cardiopulmonary Business Unit Financials, 2008-2011
Sorin - CRM Business Unit Financials, 2008-2011
Sorin - Heart Valve Business Unit Financials, 2008-2011
Sorin - Annual Revenues by Geographic Area, 2008-2011
Sorin - Main Group Company Performances, 2008-2011
Sorin – Five-Year Financial Summary
Sorin - Employees by Geographic Region, 2007-Q1 2012
Sorin – Cardiopulmonary Product Summary
Sorin Cardiopulmonary Competitive Positioning, 2010
Sorin – CRM Product Summary
Sorin CRM Competitive Positioning, 2010
Sorin Heart Valve Competitive Positioning, 2010
Sorin - Annual R&D Expenditure, 2007-2011
Sorin - R&D Facilities

LIST OF CHARTS

Sorin - Annual Revenue and EBIT, 2007-2011
Sorin - Annual Revenues by Business Segment, 2007-2011
Sorin - Annual Sales by Product Area, 2008-2011
Sorin - Annual Sales by Geographic Area, 2008-2011
Cardiopulmonary Market, 2010 and forecast 2015
CRM Market, 2010 and forecast 2015
Heart Valve Market, 2010 and forecast 2015
Skip to top


Ask Your Question

Sorin Medical Device Company Intelligence Report
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: